Frontiers of COVID-19 (eBook)

This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of 'herd immunity' and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward. 

Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.

Sasan Adibi, PhD, Senior Member, IEEE

School of IT

Deakin University

Melbourne, Australia

A/Prof Paul Griffin

B.Sc. (Hons), MBBS, FRACP, FRCPA, FACTM

School of Medicine, University of Queensland, Queensland, Australia

Department of Infectious Diseases, Mater Health, Queensland, Australia

Melvin Sanicas, MD, MSc, FRSPH, FRSA

Senior Medical Director, Global Medical Affairs

Clover Biopharmaceuticals

Zurich, Switzerland

Maryam Rashidi, MD, PhD

Senior Postdoctoral Researcher

Immunology and Inflammation

Walter & Eliza Hall Institute of Medical Research (WEHI)

Melbourne, Australia

Francesco Lanfranchi, MD

Nuclear Medicine Unit

University of Genoa

Genoa, Italy